// App-Quantinova.ai

: Genomic biomarkers to predict outcome in Gleason Score 9-10 disease.

Researchers

Presenter

  • Amar Upadhyaya Kishan

Principal Investigators

  • Tahmineh Romero

  • David Elashoff

  • Tristan Grogan

  • Matthew Rettig

  • Robert Evan Reiter

  • Phuoc T. Tran

  • Paul L. Nguyen

  • Nicholas George Nickols

  • Elai Davicioni

  • Daniel Eidelberg Spratt

  • Felix Y Feng

  • Joanne B. Weidhaas

Medical Centers

  • University of California, Los Angeles, Los Angeles, CA

  • UCLA and the Jonsson Comprehensive Cancer Center, Los Angeles, CA

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • Dana-Farber-Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA

  • University of California Los Angeles - David Geffen School of Medicine, Los Angeles, CA

  • GenomeDx Biosciences Inc., Vancouver, BC, Canada

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

  • Yale University School of Medicine, New Haven, CT

Locations

  • United States

  • Canada

Companies

  • GenomeDx Biosciences

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved